General Information
Version
3.1
Revision date
2025-07-14
Product name
Clonidine Transdermal System
Product Synonyms
Clonidine Transdermal System, USP 0.1 mg/day; Clonidine Transdermal System, USP 0.2 mg/day; Clonidine Transdermal
1.2.1 Relevant identified uses
For external use only. Pharmaceutical. Use only as directed The intent of this safety data sheet (SDS) is to provide safety information for occupational handling of this product. This information may not be relevant for medical use of this product. Pati...
Emergency telephone
+1-813-248-0585, 1-800-255-3924, +1 877-446-3679
Icons in SDS
Company Information
company name
Mylan Inc
e-mail address of the competent person responsible for the Safety Data Sheet
SDScontact@viatris.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H370
Hazard statements
Code
Statements
H370
Causes damage to organs
Section 2
SECTION 2: Hazards identification
Pharmaceutical Agent – Handling of this product in its final form presents minimal occupational exposure risk Patients/Consumers: Please refer to the product information insert or product label for appropriate consumer-specific information about this product when used according to the physician’s directions
2.1 Classification of the substance or mixture
Specific target organ toxicity (single exposure), Category 1 ( Cardiovascular system )
Signal word
Danger
Hazard statements
H370 - Causes damage to organs ( Cardiovascular system )
Prevention
Do not breathe dust/fume/gas/mist/vapors/spray
Response
IF exposed: Call a POISON CENTER or doctor Specific treatment (see supplemental first aid instructions on this label)
Storage
Store locked up
Precautionary statements
Disposal Dispose of contents/container to an approved waste disposal plant
Other hazards
No information available Unknown acute toxicity No information available
